A California biotech steps into the viral vector space with new site build of $75M

As cell and gene therapy gets hotter, a California CDMO has made a play to open an entirely new arm of its operations to fill a void in the market.

Avid Bioservices will move into the cell and gene therapy market, with the construction of a 53,000 square-foot viral vector cGMP manufacturing site down the road from its Tustin, CA headquarters.